The good stuff is there (hinted in the webinar about US agreement) just unable to be confirmed officially until regulatory approvals are given.
Aldo made it clear the sophs & instos were queing up and the book for the placement was already at $5million 1 week ago when we were in a halt at 5.3 cents.
if they had raised $5million at a discounted 4.5cents only to sophs & instos = 111 million shares. approx 15% dilution, existing shareholders get none of it.
nzs obviously decided against that & there has to be a reason why they would choose this pathway otherwise it would be one of the silliest moves of all time. They would be killing their values as significant shareholders as well dont forget.
if they are confident we will get agreements signed by the end of the month and share price sits higher, then not only are they being diligent with less dilution but they are also allowing us shareholders to participate in that.
short term pain but could end up being a masterstroke.
for example if the raise price in a month is 6cents - thats 83 million new shares instead of 111 million had they included instos now at say 4.5cents. Overall dilution of 11% instead of 15%. Its almost 30million less shares dilution and existing shareholders get to take 50million of that 83 million as well. assuming only $5mill is raised - 3mill shareholders & 2 mill instos.
NZS Price at posting:
4.6¢ Sentiment: Hold Disclosure: Held
(20min delay)